[P2–367]: CROSS‐SECTIONAL CORRELATION BETWEEN GTP1‐TAU‐PET AND CSF TAU AS MEASURES OF TAU BURDEN IN ALZHEIMER's DISEASE
Kristin R. Wildsmith(Eisai (United States)), Robby M. Weimer(Sunesis (United States)), Kaj Blennow(Sahlgrenska University Hospital), Michael E. Ward(National Institutes of Health), Marcel P. van der Brug(Scripps Research Institute), Gai Ayalon, Kina Höglund(Sahlgrenska University Hospital), Jan Mařı́k(UC Davis Comprehensive Cancer Center), Paul T. Manser, Sandra Sanabria Bohórquez, Thomas Bengtsson(WeMind), Geoffrey A. Kerchner(Roche (Switzerland))
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k